A University of Alberta pharmacology researcher has discovered that a new experimental anti-obesity drug improves diastolic ...

Exposure to antitumor necrosis factor (anti-TNF) therapy during the first 140 days of pregnancy is associated with a significant decrease in the risk of developing gestational diabetes (GD ...